New Cancer Therapies Expand Options for Patients

Recent advances in cancer treatment emphasize several innovative approaches. Nuclear medicine, particularly theragnostics, now uses radioactive molecules to both detect and selectively destroy tumors, offering new hope for prostate and thyroid cancer patients. Immunotherapy, including immune checkpoint inhibitors such as pembrolizumab and nivolumab, has revolutionized care by enabling the immune system to more effectively target cancer cells and has shown durable responses across multiple cancer types. Combination therapies targeting enzymes like PRMT5 are providing new options for hard-to-treat lung, brain, and pancreatic cancers, especially those with specific genetic deletions. These treatments, either individually or together, are expanding the range of options for patients unresponsive to standard therapies. The landscape of oncology is rapidly evolving as these breakthroughs move toward broader clinical use.